EUVIMEDEUVIMED entdecken
Crossref

PDL1 and IDO ‐2 Immunohistochemistry in Bronchoalveolar Lavage Versus Bronchoscopic Biopsy of Non‐Small Cell Lung Cancer

Menna Allah Hesham Mohammed Fekry, Yosria Mohammed El-Gohary, Hesham Radwan Abd-Elaziz, Tarek Hamdy Hassan, Mona Mostafa Ahmed iD

Cytopathology · 2026

DOI: 10.1111/cyt.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytopathology, 2026. Verfasst von Menna Allah Hesham Mohammed Fekry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Indoleamine-Pyrrole 2,3,-Dioxygenase, B7-H1 Antigen, Lung Neoplasms. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Cytology specimens are less invasive than tissue biopsies, and in some cases of non‐small cell lung cancer (NSCLC), they may be the only available material. The expression of programmed death ligand‐1 (PD‐L1) and indoleamine 2‐3 dioxygenase 2 (IDO‐2) predicts the response to new treatment modalities. The aim of the study was to investigate the validity of cell blocks prepared from cytology for evaluation of PD‐L1 and IDO‐2 expression in NSCLC and to compare the expression of these markers in cell blocks and the corresponding tissue sample. Material This cross‐sectional study included 32 specimens of bronchoalveolar lavage (BAL) cytology and their cell block preparations. Among them, 20 cases also had bronchoscopic biopsy. PD‐L1 and IDO‐2 immune staining were done for all cases.

Results

A statistically significant association is observed between high PD‐L1 expression and both tumour size ( p = 0.00014) and grade ( p = 0.00001). High IDO‐2 expression is associated with low TILs ( p = 0.03). Results of PD‐L1 and IDO‐2 expression in bronchoscopic biopsy and cell block preparations of the same cases showed no statistical difference ( p = 0.246).

Conclusion

There was no significant difference in PD‐L1 and IDO‐2 expression between cytological and bronchoscopic biopsies of lung cancer, which supports the effective use of cytological specimens and reduces the need for more invasive procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungIndoleamine-Pyrrole 2,3,-DioxygenaseB7-H1 AntigenLung NeoplasmsHumansMaleFemaleBronchoscopyMiddle AgedAgedBronchoalveolar LavageImmunohistochemistryBiopsyBiomarkers, TumorCross-Sectional StudiesBronchoalveolar Lavage FluidAged, 80 and overAdult

Stichwörter der Autor:innen

IDO‐2PD‐L1bronchoalveolar lavagecytologylung cancertru‐cuts

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseB7-H1 AntigenCD274 protein, humanIDO2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Pathology Department, Zagazig University, Zagazig, Egypt.
  • Chest Department Faculty of Medicine, Zagazig University, Zagazig, Egypt.

ORCID-Profile: Mona Mostafa Ahmed

Zitieren

APA

Fekry, M. A. H. M., El-Gohary, Y. M., Abd-Elaziz, H. R., Hassan, T. H., & Ahmed, M. M. (2026). PDL1 and IDO ‐2 Immunohistochemistry in Bronchoalveolar Lavage Versus Bronchoscopic Biopsy of Non‐Small Cell Lung Cancer. Cytopathology. https://doi.org/10.1111/cyt.70037

Vancouver

Fekry MAHM, El-Gohary YM, Abd-Elaziz HR, Hassan TH, Ahmed MM. PDL1 and IDO ‐2 Immunohistochemistry in Bronchoalveolar Lavage Versus Bronchoscopic Biopsy of Non‐Small Cell Lung Cancer. Cytopathology. 2026. doi:10.1111/cyt.70037

BibTeX
@article{Fekry2026,
  author = {Fekry, Menna Allah Hesham Mohammed and El-Gohary, Yosria Mohammed and Abd-Elaziz, Hesham Radwan and Hassan, Tarek Hamdy and Ahmed, Mona Mostafa},
  title = {PDL1 and IDO ‐2 Immunohistochemistry in Bronchoalveolar Lavage Versus Bronchoscopic Biopsy of Non‐Small Cell Lung Cancer},
  journal = {Cytopathology},
  year = {2026},
  doi = {10.1111/cyt.70037}
}
Kostenlos starten →